# US 2025/0157656 A1 · Predicting Glycogen Storage Diseases (Pompe Disease) And Decision Support

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0157656 A1
- Document ID: US20250157656A1
- Status: Published application
- Kind: A1
- Application number: 19/026,048
- Filed: 2025-01-16
- Published: 2025-05-15
- Earliest claimed: 2017-03-06
- Assignees: Cerner Innovation, Inc.
- Applicants: Cerner Innovation, Inc.
- Inventors: Douglas S. McNair
- Web page: https://patentgrep.com/patent/US20250157656A1

## CPC

- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G06N 7/01: Probabilistic graphical models, e.g. probabilistic networks
- G06N 20/00: Machine learning
- G06N 20/10: using kernel methods, e.g. support vector machines [SVM]
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

A diagnostic and decision support technology is provided for determining the presence, identity, and/or severity of an inherited lysosomal storage disorder. In particular, a mechanism is provided to detect and classify a lysosomal storage disorder in a human patient, which utilizes a logistic regression classifier determined based on a multi-variable-composite-biomarker comprising a specific set of physiological variables of the patient. This multi-variable statistical predictive biomarker approach may be employed for identifying persons whose attributes are consistent with features or glycogen storage diseases, such as late-onset Pompe disease.

## Claims

### Claim 1

A computerized method of initiating an electronic health record (EHR) intervention action for glycogen storage disease, the method comprising:
determining a multi-variable biomarker based on a set of physiological variables associated with an individual that is received as input data;
utilizing a trained multi-variable logistic regression statistical model, determining a probability of a clinically significant glycogen storage disease for the individual based on the multi-variable biomarker; and
based on the probability of the clinically significant glycogen storage disease for the individual, automatically modifying treatment of the patient, ordering additional diagnostics for the patient, scheduling treatment or diagnostics for the patient, and issuing a notification to a caregiver associated with the patient.
